Mumbai, India

Ramchandra G Naik

This inventor holds 2 USPTO granted patents. Top assignee: Hoechst Aktiengesellschaft. Active years: 1990-1994.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ramchandra G Naik. Retrieved from https://idiyas.com/inventor/ramchandra-g-naik

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 5.5

ph-index = 2

Forward Citations = 100(Granted Patents)


Company Filing History:


Years Active: 1990-1994

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Ramchandra G Naik: Innovator in Pharmaceutical Chemistry

Introduction

Ramchandra G Naik is a notable inventor based in Bombay, India. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that have therapeutic applications.

Latest Patents

Ramchandra G Naik holds 2 patents. His latest patents include innovations related to oncogene-encoded kinases inhibition using 4-H-1-benzopyran-4-one. These compounds are designed to control tumors effectively. Additionally, he has developed novel 4H-1-benzopyran-4-one derivatives that serve as anti-inflammatory, analgesic, immuno-suppressive, and anti-allergic agents. The specific compounds he has patented include various substituents that enhance their pharmacological properties.

Career Highlights

Ramchandra G Naik is associated with Hoechst Aktiengesellschaft, a prominent company in the pharmaceutical industry. His work has been instrumental in advancing the understanding and application of benzopyran compounds in medicine.

Collaborations

He has collaborated with notable coworkers such as Richard H Rupp and Samba Laxminarayan Kattige, contributing to a dynamic research environment that fosters innovation.

Conclusion

Ramchandra G Naik's contributions to pharmaceutical chemistry highlight his role as an innovator in the field. His patents reflect a commitment to developing effective therapeutic agents that can significantly impact healthcare.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…